About PPA   |   Contact Us   |   Report Abuse   |   Sign In   |   Join Now
Addressing Pennsylvania's Opioid Crisis: What the Health Care Team Needs to Know

Opioid use and abuse is a major public health concern in Pennsylvania. To fully address this problem, it will take a collaborative approach to prescribing, monitoring, and educating the patients and families that we serve.

 
These continuing education programs are a collaboration between numerous groups including the Pennsylvania Pharmacists Association, the Pennsylvania Medical Society, the Pennsylvania State Nurses Association, the Pennsylvania Department of Health, and others. Each session consists of four, 15-minute modules. The programs cover a variety of tools and resources for prescribers and dispensers to better address opioid addiction with their patients.
  

As part of our commitment to be a partner in solving the opioid epidemic, PPA is providing CE credit free for these modules at no charge to both members and non-members through December 31, 2016.

 

Please read the following information about each continuing pharmacy education (CPE) activity before viewing the presentation.

Requirements to Receive CE Credit: View the entire module, complete an evaluation survey, and pass a short quiz (minimum 70%). CPE Monitor ID and birthday must be provided or on file with PPA.

   

  

Session 1: Pennsylvania Opioid Guidelines – What Health Care Teams Need to Know

Target Audience: Pharmacists and Pharmacy Technicians

UAN: 0159-9999-15-090-H01-P & 0159-9999-15-090-H01-T

Release Date: December 29, 2015

Expiration Date: December 29, 2018

Activity Type: Knowledge-based

CE Credit: 1 Contact Hour (0.1 CEU)

Program Objectives:
At the completion of this activity, the participant will be able to:
1. Name two reasons why you should care about the guidelines.
2. Identify why the guidelines were created.
3. Indicate how the Pennsylvania guidelines make it simple to prescribe.
4. Identify four separate guidelines addressing opioid prescriptions.
5. List state opioid prescribing limitations.
6. Identify statistics associated with opioid related deaths.
7. Identify components of the guidelines that are used to prescribe opioids.
8. List how the guidelines can help benefit prescribers.
9. Recall the goal of the task force.
10. List ED key provisions.
11. Recognize red flags in the ED.
12. Identify concepts of the PA controlled substances database.
13. Describe how pharmacists can query the database.
14. Describe responsibilities associated with opioid use as a pain treatment in dental care.
15. List key practices on the prescribing of opioids in the dental practice. 

  

 

                  VIEW Session 1                          GET CE CREDIT for Session 1

 

Session 2: Naloxone – What Health Care Teams Need to Know

Target Audience: Pharmacists and Pharmacy Technicians

UAN: 0159-9999-16-007-H03-P & 0159-9999-16-007-H03-T

Release Date: February 18, 2016

Expiration Date: February 18, 2019

Activity Type: Knowledge-based

CE Credit: 1 Contact Hour (0.1 CEU)

 

At the completion of this activity, the participant will be able to:

Program Objectives for Pharmacists:
1. Articulate the purpose of naloxone treatment.
2. Describe Act 139 and its role in the availability of naloxone.
3. Identify the legal protections provided for in Act 139.
4. Address common concerns associated with naloxone.
5. Describe the role of first responders in preventing overdose deaths.
6. Identify the requirements of first responder agencies according to Act 139.
7. Describe Act 139's allowance for 3rd party prescribing.
8. Educate patients on Act 139's immunity provisions.
9. Identify the signs and symptoms of opioid overdose.
10. Describe how Naloxone stops an opioid overdose.
11. Administer the intra-nasal and auto-injector versions of Naloxone during an accidental opioid overdose.
 Program Objectives for Pharmacy Technicians:
1. Articulate the purpose of naloxone treatment.
2. Describe Act 139 and its role in the availability of naloxone.
3. Identify the legal protections provided for in Act 139.
4. Address common concerns associated with naloxone.
5. Describe the role of first responders in preventing overdose deaths.
6. Identify the requirements of first responder agencies according to Act 139.
7. Describe Act 139's allowance for 3rd party prescribing.
8. Educate patients on Act 139's immunity provisions.
9. Identify the signs and symptoms of opioid overdose.
      

  

                  VIEW Session 2                          GET CE CREDIT for Session 2
 
 

Session 3: Addressing Pennsylvania’s Opioid Crisis: Referral to Treatment

  

Target Audience: Pharmacists and Pharmacy Technicians

UAN:0159-9999-16-017-H04-P & 0159-9999-16-017-H04-T

Release Date: July 20, 2016

Expiration Date: July 20, 2019

Activity Type: Knowledge-based

CE Credit: 1 Contact Hour (0.1 CEU)

  

At the completion of this activity, the participant will be able to:

Program Objectives for Pharmacists:
1. Discuss the factors influencing substance use disorders.
2. Identify types of care and supports available for substance use disorder treatment.
3. Describe levels of care available for varying severities of substance use disorders.
4. Identify screening tools to help identify and assess patients whose substance use puts them at increased risk for harm.
5. Role-play brief intervention strategies.
6. Discuss steps in the referral process and how to conduct a referral.
7. Use techniques to conduct a brief intervention and warm handoff to treatment.
8. Describe possible barriers to patient compliance, such as stigma.
9. Discuss challenges with client motivation and techniques to resolve them.
10. Identify the provider's role during the process of warm-hand off including the front end, during, after and throughout the process.
11. Consider next steps and resources for additional training and information.
Program Objectives for Pharmacy Technicians:
1. Discuss the factors influencing substance use disorders.
2. Identify types of care and supports available for substance use disorder treatment.
3. Describe levels of care available for varying severities of substance use disorders.
4. Describe possible barriers to patient compliance, such as stigma.
5. Consider next steps and resources for additional training and information.
     
     
                  VIEW Session 3                          GET CE CREDIT for Session 3
   

Session 4: Pennsylvania's Prescription Drug Monitoring Program

Target Audience: Pharmacists and Pharmacy Technicians

UAN:0159-9999-16-029-H04-P & 0159-9999-16-029-H04-T

Release Date: July 20, 2016

Expiration Date: July 20, 2019

Activity Type: Knowledge-based

CE Credit: 1 Contact Hour (0.1 CEU)

  

At the completion of this activity, the participant will be able to:

Program Objectives for Pharmacists:
1. Articulate the need for a comprehensive program to monitor controlled substance prescriptions, including opioids.
2. Identify how Prescription Drug Monitoring Programs, or PDMPs, can increase the quality of patient care.
3. Describe how other states are using PDMPs.
4. Describe the operation of Pennsylvania's PDMP.
5. Articulate prescriber and dispenser roles and responsibilities.
6. Identify reasons to query the system.
7. Discuss third-party access to the data and safeguards to protect the data.
Program Objectives for Pharmacy Technicians:
1. Articulate the need for a comprehensive program to monitor controlled substance prescriptions, including opioids.
2. Describe how other states are using PDMPs.
3. Describe the operation of Pennsylvania's PDMP.
4. Identify reasons to query the system.
5. Discuss third-party access to the data and safeguards to protect the data.

     

     

                  VIEW Session 4                          GET CE CREDIT for Session 4
    

   

Session 5: Pennsylvania's PDMP - Be smart. Be safe. Be sure.

Target Audience: Pharmacists and Pharmacy Technicians

UAN: 0159-9999-16-036-H04-P & 0159-9999-16-036-H04-T

Release Date: September 7, 2016

Expiration Date: September 7, 2019

Activity Type: Knowledge-based

CE Credit: 15 Minutes (0.025 CEU)

At the completion of this activity, the participant will be able to:

Program Objectives for Pharmacists:
1. Outline a plan to review and incorporate PDMP data into clinical decision making process
2. Identify potential "red flags" that you should consider in the patient PDMP record
3. Review practice case studies
Program Objectives for Pharmacy Technicians:
1. Outline your role as a pharmacy technician in reviewing and incorporating PDMP data into your pharmacy practice site’s dispensing process
2. Identify potential "red flags" in the PDMP record that may require action

     

     

                  VIEW Session 5                          GET CE CREDIT for Session 5

 

 

Planners and Faculty:

Michael Ashburn, MD; David Blunk; Lorraine Bock, CRNP; James Boyle, DDS; Benjamin Carr, MPAS, PA-C; Mary Jo Cerepani, DNP; Scot Chadwick, JD; Michael Consuelos, MD; Mike Davis; Susan DeSantis, PA-C; Patricia Epple; Cynthia Ferrari, PA-C; Thomas Franko, PharmD; Michael Fraser, PhD; Katherine Galluzzi, DO; Gus Gerraci, MD; Joseph Gershey, DPM; John Goldman, MD; Donna Hazel, RPh; Leslie Howell; Erik Huet; Camille Kostelac-Cherry; Rachel Levine, MD; Bruce MacLeod, MD; Ken Martz; Angie Mays, MD; Aislyn Moyer, RN; Sonia Reich, CRNP; Jan Reisinger; Ben Reynolds, PA-C; Cheri Rinehart; Angela Rupert; Susan Schrand, CRNP; Daneen Schroder; Patricia Sweeney, PhD, CRNP; David Talenti, MD; Gary Tennis; Michael Young, FACHE

 

 

The Pennsylvania Pharmacists Association is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
 

 

Association Management Software Powered by YourMembership.com®  ::  Legal